Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

NCT06046963 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Peritoneal Metastases
Ascites, Malignant

Interventions

DRUG: Sintilimab in Combination With S-1/oxaliplatin With nab-paclitaxel intraperitoneal infusion
OTHER: Blood samples, tumor biopsy specimens, ascites, and feces samples will be collected

Sponsor

Zhejiang Cancer Hospital